# Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

> **NCT01135368** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 506 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT01135368
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 506 (ACTUAL)
- **Last updated:** 2012-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135368, "Safety and Efficacy of Lansoprazole in Patients With Reflux Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01135368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*